Both in Pharmaceuticals
PMGC Holdings vs Genprex
Over the past year ELAB returned −99.8% and GNPX returned −98.7%; their daily moves had a correlation of -0.01.
ELAB −99.8% GNPX −98.7%Growth of $1, one year, split-adjusted
| Metric | ELAB | GNPX |
|---|---|---|
| Price | $3.05 | $2.69 |
| Market cap | $2.5M | $2.2M |
| Today | −0.97% | −1.10% |
| 1 month | −32.5% | −19.7% |
| 6 months | −94.0% | −89.9% |
| Year to date | −99.1% | −93.0% |
| 1 year | −99.8% | −98.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | 29.5% | — |
| Net margin | −225.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | $9.4M | $15.2M |
| Dividend yield | — | — |
| Volatility (60d) | 677.0% | 99.6% |
| Short % of float | 0.6% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).